Safety And Efficacy Of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells For The Treatment Of Aml Relapsed After Allogeneic Stem Cell Transplantation: A First In-Human Phase I/Iia Clinical Trial
BLOOD(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要